Answers are grounded in this paper and cite their sources.
A low dose of rituximab is an effective and safe treatment for pemphigus. Relapses may occur, mostly at the end of the second year. Cost-effectiveness studies with a long follow-up are required to determine the proper dosage of this expensive drug in pemphigus.
No takes yet. Share an insight, caveat, or question.
Horváth et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: